Inexpensive, serotype-independent protocol for native and bioengineered recombinant adeno-associated virus purification
Main Article Content
Keywords
adeno-associated virus, purification, PEG8000, centrifugation, inexpensive
Abstract
Recombinant adeno-associated virus (AAV) is a valuable and often used gene therapy vector. With increased demand for highly purified virus comes the need for a standardized purification procedure that is applicable across many serotypes and includes bioengineered viruses. Currently cesium chloride banding or affinity chromatography are the predominate forms of purification. These approaches expose the final purified virus to toxic contaminants or are highly capsid dependent and may require significant optimization to isolate purified AAV. These methods may also limit crude viral lysate processing volume resulting in a significant loss of viral titer. To circumvent these issues, we have developed an AAV purification protocol independent of toxic compounds, supernatant volume and capsid moiety. This purification method standardizes virus purification across native serotype and bioengineered mosaic capsids.
Downloads
Metrics
References
2. Wang J, Faust SM, Rabinowitz JE. The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes. J Mol Cell Cardiol. 2016;50(5):793–802.
3. Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G, et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther. 2008;19(12):1359–68.
4. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16(6):1073–80.
5. Palomeque J, Chemaly ER, Colosi P, Wellman J a, Zhou S, Del Monte F, et al. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther. 2007;14(13):989–97.
6. Asokan A, Samulski RJ. An Emerging Adeno-Associated Viral Vector Pipeline for Cardiac Gene Therapy. Hum Gene Ther. 2013;24(11):906–13.
7. Wang W, Barnabei MS, Asp ML, Heinis FI, Arden E, Davis J, et al. Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance. Nat Med. 2013;19(3):305–12.
8. Guo P, Xiao X, El-Gohary Y, Paredes J, Prasadan K, Shiota C, et al. A simplified purification method for AAV variant by polyethylene glycol aqueous two-phase partitioning. Bioengineered. 2013;4(2):103–6.
9. Guo P, El-Gohary Y, Prasadan K, Shiota C, Xiao X, Wiersch J, et al. Rapid and simplified purification of recombinant adeno-associated virus. J Virol Methods. 2012;183(2):139–46.
10. Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani JG, Alauddin MM, et al. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc. 2007;2(3):523–31.
11. Miyake K, Miyake N, Yamazaki Y, Shimada T, Hirai Y. Serotype-independent Method of Recombinant Adeno-associated Virus (AAV) Vector Production and Purification. J Nippon Med Sch. 2012;79(6):394–402.
12. Yang L, Jiang J, Drouin LM, Agbandje-Mckenna M, Chen C, Qiao C, et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc Natl Acad Sci U S A. 2009;106(10):3946–51.
13. Griger JC, Soltys SM, Samulski RJ. Production of recombinant adeno-associated virus vectors using suspensio HEK293 cells and continous harvest of vector from the culture media for GMP FlX and FLT1 clinical vector. Mol. Ther. U.S.A 2015;18(10):1-11.
Article Sidebar
Article Details
Authors who publish with JBM agree to the following terms:
- Authors retain copyright and grant JBM right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
